Traduction de «innovations in information technology » (Néerlandais → Français) :

As in our daily lives, innovations in information technology are also playing an increasing part in healthcare.
As in our daily lives, innovations in information technology are also playing an increasing part in healthcare.

– Health statistics – key data on health 2002 (data 1970-2001), 427. – Science, technology and innovation in Europe, Eurostat Pocketbooks, 2007, 8
– Science, technology and innovation in Europe, Eurostat Pocketbooks, 2007 edition, p. 8 (ISSN 1725-5821).

Het Geneesmiddelenbureau zal dergelijke inspanningen blijven ondersteunen, in het bijzonder via zijn steun aan het Initiatief inzake innovatieve geneesmiddelen (Innovative Medicines Initiative), het zevende kaderprogramma en het Europese technologieplatform voor wereldwijde diergezondheid (European Technology Platform for Global Animal Health).
L’Agence va continuer à contribuer à ces efforts en soutenant, en particulier, l’initiative sur les médicaments innovants, le septième programme-cadre et la plateforme technologique sur la santé animale dans le monde.

Continue ondersteuning van de Europese Commissie bij de fasen die leiden tot de nieuwe regelgeving betreffende geavanceerde behandelingen, deelname aan de activiteiten van het Initiatief inzake innovatieve geneesmiddelen (Innovative Medicines Initiative) voor geneesmiddelen voor menselijk gebruik, het Europese technologieplatform voor wereldwijde diergezondheid (European Technology Platform for Global Animal Health) voor diergeneesmiddelen en aan andere internationale initiatieven ter verbetering van geneesmiddelontwikkeling.
l’initiative sur les médicaments innovants pour les médicaments à usage humain, à la plateforme technologique européenne sur la « santé animale dans le monde » pour les médicaments à usage vétérinaire, et aux autres initiatives internationales œuvrant pour l’amélioration du développement des médicaments.

Daarnaast neemt het Geneesmiddelenbureau actief deel aan initiatieven op EU-niveau, waaronder het Initiatief inzake innovatieve geneesmiddelen (Innovative Medicines Initiative), het Europese technologieplatform voor wereldwijde diergezondheid (European Technology Platform for Global Animal Health) en het zevende kaderprogramma.
Elle participe aussi activement aux initiatives communautaires comme l’initiative sur les médicaments innovants, la plateforme technologique européenne sur la santé animale dans le monde et le septième programmecadre.

This release contains forward-looking information about an agreement by Pfizer to acquire FoldRx, and about FoldRx’s product candidate tafamidis, its other clinical and preclinical development programs and its technology platform, including their potential benefits, that involves substantial risks and uncertainties. Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and in its reports on Form 10-Q and Form 8-K.
Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments.

Information and Communication Technology (ICT)
Information and Communication Technology (ICT)

The FAMHP’s Information & Communication Technology (ICT) service gives support in the area of IT and provides the FAMHP with suitable and effective tools.
The FAMHP’s Information & Communication Technology (ICT) service gives support in the area of IT and provides the FAMHP with suitable and effective tools.

Support services 45 Budget & Management Control 45 Information & Communication Technology 49 Legal service 52 Translation service 53 Personnel & Organisation 53
Support services 45 Budget & Management Control 45 Information & Communication Technology 49 Legal service 52 Translation service 53 Personnel & Organisation 53

Among others, these include Budget & Management Control (B&Mc), Information & Communication Technology (ICT), the Legal service, Personnel & Organisation (P&O), the Translation service, Communication & Scientific support, International Relations, PMO (the support monitoring unit), Internal Audit & Quality and the Crisis unit (non-permanent).
Among others, these include Budget & Management Control (B&Mc), Information & Communication Technology (ICT), the Legal service, Personnel & Organisation (P&O), the Translation service, Communication & Scientific support, International Relations, PMO (the support monitoring unit), Internal Audit & Quality and the Crisis unit (non-permanent).